13F-HR filed by Alphabet Inc.
Alphabet Inc. filed this 13F-HR for the quarter ended 2025-12-31, filed 2026-02-13, with 29 holding rows worth $2,579,790,897.
- Accession
- 0001652044-26-000023
- Filer
- CIK 1652044
- Filed
- 2026-02-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2025
A holdings report, 32 entries on the cover page, a total value of $2,579,790,897 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,579,790,897 with VALUE read as dollars as filed, 13F file number 028-22702. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerGV Management Company, L.L.C.028-22704
- included managerGoogle LLC028-22705
- included managerCapitalG II LP028-22706
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| AST SPACEMOBILE INC COM CL A | 00217D100 | Stock | 8,943,486 | $649,565,388 | dollars as filed | |
| PLANET LABS PBC | 72703X106 | COM CL A | 31,942,641 | $629,908,881 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 3,345,102 | $266,437,374 | dollars as filed | |
| ARM HOLDINGS PLC | 042068205 | SPONSORED ADS | 1,960,784 | $214,333,299 | dollars as filed | |
| FRESHWORKS INC CLASS A COM | 358054104 | Stock | 16,206,643 | $198,531,377 | dollars as filed | |
| UIPATH INC | 90364P105 | CL A | 7,034,337 | $115,292,783 | dollars as filed | |
| GITLAB INC CLASS A COM | 37637K108 | Stock | 2,724,712 | $102,258,441 | dollars as filed | |
| TEMPUS AI INC CL A | 88023B103 | Stock | 1,551,102 | $91,592,573 | dollars as filed | |
| DEXCOM INC COM | 252131107 | Stock | 1,036,937 | $68,821,509 | dollars as filed | |
| MAZE THERAPEUTICS INC COM | 578784100 | Stock | 1,388,583 | $57,528,994 | dollars as filed | |
| PRIME MEDICINE INC | 74168J101 | COM | 16,562,498 | $57,471,868 | dollars as filed | |
| BRIDGEBIO ONCOLOGY THERAPEUT | 107924102 | COM NEW | 2,823,126 | $35,345,538 | dollars as filed | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 1,568,753 | $13,271,651 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 241,264 | $12,217,609 | dollars as filed | |
| MONTE ROSA THERAPEUTICS INC | 61225M102 | COM | 744,948 | $11,680,785 | dollars as filed | |
| SANA BIOTECHNOLOGY INC | 799566104 | COM | 2,812,500 | $11,446,875 | dollars as filed | |
| LYELL IMMUNOPHARMA INC COM NEW | 55083R203 | Stock | 293,256 | $9,026,420 | dollars as filed | |
| BEAM THERAPEUTICS INC | 07373V105 | COM | 321,604 | $8,914,863 | dollars as filed | |
| FIGMA INC CL A | 316841105 | COM | 215,582 | $8,056,299 | dollars as filed | |
| OSCAR HEALTH INC | 687793109 | CL A | 481,988 | $6,926,168 | dollars as filed | |
| GENEDX HOLDINGS CORP | 81663L200 | COM CL A | 22,711 | $2,953,793 | dollars as filed | |
| EXACT SCIENCES CORP COM | 30063P105 | Stock | 23,205 | $2,356,700 | dollars as filed | |
| SPERO THERAPEUTICS INC | 84833T103 | COM | 889,979 | $2,073,651 | dollars as filed | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 698,262 | $1,389,541 | dollars as filed | |
| HYPERFINE INC | 44916K106 | Common Stock | 898,720 | $880,746 | dollars as filed | |
| TENAYA THERAPEUTICS INC | 87990A106 | COM | 915,705 | $650,151 | dollars as filed | |
| CORTEXYME INC | 22053A107 | COM | 189,122 | $633,559 | dollars as filed | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 14,262 | $161,303 | dollars as filed | |
| REPLIGEN CORP COM | 759916109 | Stock | 383 | $62,758 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001652044-26-000023 | this filing | 2026-02-13 | acceptance time not in the bulk data set |